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Background: The reported health benefits of Korean red ginseng (KRG) include antioxidant, antitumor,
antimutagenic, and immunomodulatory activities; however, the effects on oxidative stress have not yet been
evaluated. Therefore, we assessed the effect of KRG on antioxidant enzymes and oxidative stress markers in
humans.
Methods: We conducted a randomized, double-blind, placebo-controlled study with three groups, including
placebo, low-dose (3 g/day), and high-dose (6 g/day), which were randomly assigned to healthy subjects aged
20–65 years. Lymphocyte DNA damage, antioxidative enzyme activity, and lipid peroxidation were assessed before
and after the 8-week supplementation.
Results: Fifty-seven subjects completed the protocol. Plasma superoxide dismutase (SOD) activity after the 8-week
KRG supplementation was significantly higher in the low-and high-dose groups compared to baseline. Plasma
glutathione peroxidase (GPx) and catalase activities were also increased after the high-dose supplementation.
Furthermore, the DNA tail length and tail moment were significantly reduced after the supplementation (low-dose
and high-dose), and plasma oxidized low-density lipoprotein (LDL) levels were reduced in low-dose and high-dose
groups, but increased in the placebo group. The net changes in oxidized LDL after the supplementation differed
significantly between both KRG supplementation groups and the placebo group. Net changes in GPx, SOD and
catalase activities, and DNA tail length and tail moment were significantly different between the high-dose group
and the placebo group. Additionally, the net changes in urinary 8-epi-PGF2α were significantly different between
the KRG supplementation groups and the placebo group.
Conclusions: KRG supplementation may attenuate lymphocyte DNA damage and LDL oxidation by upregulating
antioxidant enzyme activity.
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Oxidative stress describes a set of intracellular or extra-
cellular conditions that lead to the chemical or metabolic
generation of reactive oxygen/nitrogen species, including
superoxide radicals, hydrogen peroxide (H2O2), hydroxyl
radicals, singlet oxygen, lipid hydroperoxides, peroxyni-
trite, and related species [1]. Reactive oxygen/nitrogen
species can cause oxidative damage to essential cellular
constituents, such as membrane lipids, proteins, and
DNA, which may ultimately result in cell death [2]). Aer-
obic organisms attempt to protect themselves against
oxidative damage with exogenous antioxidants (e.g., vita-
min E, ascorbic acid, and carotenoids) obtained through
the diet as well as endogenous antioxidants (e.g., gluta-
thione, glutathione peroxidase (GPx), catalase, and super-
oxide dismutase (SOD)). Furthermore, oxidative damage
mediated by the reactive oxygen species listed above is
known to contribute to the aging process and the patho-
genesis of cancer, cardiovascular disease, and other de-
generative diseases [3].
Ginseng (Panax ginseng C.A. Meyer) is a perennial
herb belonging to the Panax family (Araliaceae). Its
roots are used as a general tonic in traditional oriental
medicine to increase health, longevity, and vitality, espe-
cially in the elderly [4]. White Ginseng is known to exert
a number of effects, such as suppressing the growth and
metastasis of melanoma (B16) [5] and activating GPx
and SOD to protect against free radical damage [6].
Interest in Korean red ginseng (KRG) has grown re-
cently, as it is one of the foods that can easily be con-
sumed daily in Korea. Red ginseng is produced by
steaming and drying fresh ginseng, a process that chem-
ically transforms the components and alters their bio-
logical properties [7]. The non-saponin components of
red ginseng are thought to improve learning and mem-
ory [8], while acid polysaccharides activate natural killer
cells and stimulate interferon production [9]. Mochizuki
et al. [10] reported that 20(R)- and 20(S)-ginsenoside-
Rg3, the ginseng saponins, possess the ability to inhibit
the lung metastasis of cancer by inhibiting the invasion
and adhesion of tumor cells. According to Kubo and
Tong [11], red ginseng extract influenced tumor cell
lysosomes by promoting the uptake of mitomycin C,
which has cytocidal effects. Kim et al. [12] also found
that ginseng extracts scavenged 40% of hydroxyl radicals
at 0.1 mg/ml and completely scavenged superoxide radi-
cals at 2 mg/ml. In addition, KRG was also shown to
affect immunological markers in individuals with human
immunodeficiency virus [13]. Although a number of
pre-clinical studies have reported medicinal benefits of
KRG including antioxidant, antitumor, antimutagenic
[10-12] and a clinical study has reported immunomodu-
latory actions [13], the effects of KRG on oxidative stress
and lipid peroxidation have not been properly evaluatedin healthy subjects. Thus, we conducted a randomized,
double-blind, placebo-controlled clinical trial in healthy
subjects to evaluate the effects of KRG supplementation
on biomarkers of oxidative stress and lipid peroxidation,
which included lymphocyte DNA damage, urinary 8-epi-
prostaglandin F2α (PGF2α), plasma oxidized low-density
lipoprotein (LDL), and antioxidant enzymes.Methods
Subjects
Sixty-nine healthy subjects (aged 20–65 years) were
recruited during routine check-ups at a health promo-
tion center at Yonsei University Hospital from May to
November in 2009. Participants were asked to visit four
times (1 week before and at 0, 4, and 8 weeks). Blood
samples were taken at weeks 0 and 8, and diet and cap-
sule intakes were assessed at weeks 0, 4, and 8. Healthy
subjects who either used cigarettes or consumed alcohol
(or both) were enrolled in this study at the Laboratory
of Clinical Nutrigenetics/Nutrigenomics at Yonsei Uni-
versity. The exclusion criteria were the consumption of
more than three servings of vegetables or fruit per day,
antioxidant or vitamin/mineral supplementation, history
of chronic disease (e.g., diabetes, heart disease, renal
disease), or the use of medication (e.g., lipid-lowering or
antihypertensive medications, anti-platelets, or disease-
related medications). The participants were interviewed
to determine their smoking and drinking habits. Smok-
ing status was categorized as “current smoker” or “non-
smoker,” and alcohol consumption was categorized as
“current drinker” or “nondrinker.” Nonsmokers or non-
drinkers included both ex-consumers and those who
had never consumed. Ex-smokers and ex-drinkers were
defined as subjects who stopped smoking or drinking at
least 1 year prior to participating in the study. Current
smokers were asked the number of cigarettes smoked
per day. Current drinkers were asked about the type and
amount of alcohol consumed per day, and the amount
of alcohol was then calculated as grams per day.
The study subjects number calculation assumed a two-
tailed alpha = 0.05 and 1-β= 90% to detect a 10% differ-
ence with a standard error of 0.28 in the comet assay
which is primary outcome and an attrition rate (20%).
Biomarkers for testing antioxidant/oxidative effects and
the number of subjects were determined by following
the criteria recommended by the Korea Food and Drug
Administration. Of the 69 study subjects, 12 subjects
(placebo group, n= 4; low-dose group [3 g KRG/day],
n= 4; high-dose group, [6 g KRG/day], n= 4) discontin-
ued the study for personal reasons. No adverse reactions
(e.g., fever, hot flush, nausea, vomiting, diarrhea) due to
KRG supplementation were observed among the 57 sub-
jects who completed the study.
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Identical-looking capsules contained red ginseng (low
dose, 300 mg; high dose, 600 mg) or placebo (300 mg of
KRG-flavored capsule containing corn starch). Red gin-
seng and placebo capsules were provided by the Korea
Ginseng Cooperation (KGC, Daejeon, Korea). The red
ginseng contained 16.58 mg/g total ginsenosides, and
the ratio of protopanaxadiol ginsenosides (Rb1, Rb2, Rc,
Rd, and Rg3) to protopanaxatriol ginsenosides (Rg1, Re,
and Rf) was 1.65. Analyses of common ginsenosides
were performed in quadruplicate using standard HPLC-
UV techniques [14] at the Korean Ginseng Research In-
stitute in Daejeon, Korea.
This study design was the randomized double-blind,
placebo-controlled intervention trial for 8 week and was
approved by the Institutional Review Board of Yonsei
University (#RA-2009-650). After written informed con-
sent was obtained, subjects were randomly assigned to
placebo (n = 23) or KRG (low-dose [n = 24] or high-dose
[n = 22]) groups. All subjects were asked to take 10 cap-
sules in total per day immediately after any main meals.
For example, three capsules after breakfast, three cap-
sules after lunch, and four capsules after dinner. Compli-
ance of KRG consumption was assessed at the end of
the study by counting capsules remaining and self-
recording. If compliance was beneath 75%, the subject
dropped out. All participants were encouraged to main-
tain their usual lifestyle and dietary habits.Assessment of dietary intake and level of physical activity
The subjects’ usual diet information was obtained using
both a 24-hour recall method and a semi-quantitative
food frequency questionnaire (SQFFQ), which has been
tested previously for validity [15]. We used the former
to carry out analyses and the latter to check if the data
collected by the 24-hour recall method was representa-
tive of the usual dietary pattern.
All the subjects were given written and verbal instruc-
tions by a registered dietitian for the completion of a 3-
day (two weekdays and one weekend) dietary record
every 4 weeks. On the sheet, the subjects were instructed
to record the amount of food before ingestion and any
remaining after ingestion by weighing the foods. One
week before the start of the study, all the participants
were advised to continue their usual diet for a week and
were instructed to complete a 3-day dietary record as
the baseline measurement, which was compared with
the record obtained by 24-hour recall methods at a pre-
vious visit to check their records. The participants were
also instructed to record their physical activity in a diary
for 24 hours every 4 weeks. To check participants’ com-
pliance during the whole study period, the dietitian
interviewed them biweekly by telephone. During thestudy period, all participants were also encouraged to
maintain their usual lifestyle.
Dietary energy values and nutrient content from the 3-
day food records were calculated using the Computer
Aided Nutritional analysis program (CAN-pro 2.0, Ko-
rean Nutrition Society, Seoul, Korea). Total energy ex-
penditure (kcal/day) was calculated from activity
patterns, including basal metabolic rate, physical activity
for 24 hours [16], and specific dynamic action of food.
Basal metabolic rates for each subject were calculated
with the Harris-Benedict equation [17].
Anthropometric parameters, blood pressure, and blood
and urine collection
Body weight and height were measured without clothes
or shoes in the morning to determine the body mass
index (BMI; kg/m2). Blood pressure was measured with
an automatic blood pressure monitor (TM-2654, A&D,
Tokyo, Japan) in triplicate using the left arm of a seated
subject after a 20-min rest. After a 12 h fasting period,
venous blood specimens were collected in EDTA-treated
and plain tubes, centrifuged to produce plasma or
serum, and stored at −70°C until analysis. Urine was col-
lected in polyethylene bottles containing 1% butylated
hydroxytoluene after 12 h of fasting. The tubes were im-
mediately covered with aluminum foil and stored at −70°C
until analysis.
Serum lipid profile and fasting glucose
Fasting total cholesterol and triglycerides were measured
using commercially available kits on a Hitachi 7150
Autoanalyzer (Hitachi Ltd., Tokyo, Japan). After precipi-
tation of chylomicrons with dextran sulfate magnesium,
concentrations of LDL and high-density lipoprotein
(HDL) cholesterol in the supernatants were determined
enzymatically. In participants with serum triglyceride
concentrations below 400 mg/mL, LDL cholesterol was
indirectly measured using the Friedewald formula. Fast-
ing glucose levels were determined by the glucose oxi-
dase method using a Beckman glucose analyzer
(Beckman Instruments, Irvine, CA, USA).
Safety parameters
Serum Blood Urea Nitrogen (BUN) and creatinine con-
centrations were measured by a colorimetric method
using commercially available kits on a Hitachi 7180
Autoanalyzer (Hitachi Ltd., Tokyo, Japan). Serum aspar-
tate aminotransferase (AST) and alanine aminotransfer-
ase (ALT) were measured by a kinetic UV method based
on recommendations by the International Federation of
Clinical Chemistry (IFCC) using commercially available
kits on a Hitachi 7180 Autoanalyzer (Hitachi Ltd.,
Tokyo, Japan). A complete blood count (CBC) test was
Kim et al. Nutrition Journal 2012, 11:47 Page 4 of 9
http://www.nutritionj.com/content/11/1/47determined using the HOROBA ABX diagnostic (HOR-
IBA ABX SAS, Parc Euromedicine, France).
Alkaline comet assay for DNA damage
As a primary outcome measure, DNA damage was
assessed using the comet method described by Green
et al. [18]. Whole blood was mixed with phosphate buf-
fered saline and poured gently over a lymphocyte separ-
ation solution (Histopaque-1077, Sigma Chemical Co.,
Korea). After centrifugation at 1,450 rpm for 4 min, lym-
phocytes were transferred to another tube, mixed with
0.7% low-melting agarose, and then added to slides pre-
coated with 0.5% agarose. The slides were immersed in
freshly prepared cold lysing solution and subjected to
electrophoresis. The slides were then washed with neu-
tralizing buffer and treated with ethanol. Tail length
(μm) and tail moment (% of DNA in the tail × tail
length) were evaluated using image analysis software
(Komet 5.0, Kinetic Imaging, UK) and fluorescence mi-
croscopy (Leica, Germany) equipment with filters.
Images from 50 cells from each slide were analyzed. All
steps were performed in dim light, and the electrophor-
esis tank was covered with black paper to avoid add-
itional light-induced DNA damage.
Antioxidative enzyme activities
Plasma and erythrocyte antioxidative enzyme activities
were measured as secondary outcomes. Plasma and
erythrocyte SOD activity was determined based on the
generation of superoxide radicals produced by xanthine
and hypoxanthine. Superoxide radicals react with tetra-
zolium chloride salts to produce a red formazan dye.
SOD activity was estimated by the inhibition of this col-
orimetric reaction using an assay kit (Cayman Chemical,
Ann Arbor, MI, USA), and the absorbance at 450 nm
was measured with a Wallac Victor2 multilabel counter
(Perkin Elmer Life Sciences, Turka, Finland). The intra-
assay and inter-assay coefficients of variance were 4.43%
and 8.26%, respectively. Plasma GPx activity was indir-
ectly measured using an assay kit that involved a
coupled reaction with glutathione reductase (Cayman
Chemical). Oxidized glutathione, generated by the re-
duction of hydroperoxide by GPx, was restored to its
reduced state by glutathione reductase and nicotinamide
adenine dinucleotide phosphate (NADPH). NADPH oxi-
dation was monitored at a lower 340 nm absorbance,
which was measured with the Wallac Victor2 multilabel
counter. The intra-assay and inter-assay coefficients of
variance were 6.01% and 7.68%, respectively. Plasma and
erythrocyte catalase activity was measured based on the
generation of formaldehyde from methanol in the pres-
ence of H2O2 using an assay kit (Cayman Chemical).
Formaldehyde forms a bicyclic heterocycle with the
chromogen Purpald, which changes from colorless to apurple color when oxidized. The absorbance was mea-
sured at 540 nm with the Wallac Victor2 multilabel
counter. The intra-assay and inter-assay coefficients of
variance were 5.52% and 6.78%, respectively.
Plasma oxidized LDL concentration and Urinary
8-epi-PGF2α
As one of the secondary outcome measures, plasma oxi-
dized LDL concentration and urinary 8-epi-PGF2α excre-
tion. Plasma oxidized LDL was determined with an
enzyme immunoassay (Mercodia, Uppsala, Sweden), and
the color reaction was measured at 450 nm with the Wal-
lac Victor2 multilabel counter. The intra-assay and inter-
assay coefficients of variance were 6.52% and 8.15%,
respectively. Urinary 8-epi-PGF2α was measured using
a colorimetric enzyme immunoassay (Bioxytech urinary
8-epi-PGF2α assay kit; OXIS International Inc., OR, USA).
The resulting color was measured at 650 nm using the
Wallac Victor2 multilabel counter. Urinary creatinine was
determined using a Hitachi 7180 Autoanalyzer (Hitachi
Ltd., Tokyo, Japan) by the alkaline picrated (Jeffe) reac-
tion. Urinary 8-epi-PGF2α concentrations were expressed
as pmol/mmol of creatinine. The intra-assay and inter-
assay coefficients of variance were 4.32% and 9.57%,
respectively.
Statistical analysis
Statistical analyses were performed with SPSS version
12.0 for Windows (Statistical Package for the Social
Sciences (SPSS) Inc., Chicago, IL, USA). We used the
Wilcoxon signed-rank test to determine within-group
differences of biochemical parameters before (baseline)
and after the intervention. The nonparametric Kruskal-
Wallis test and analysis of covariance (ANCOVA) using
the general linear model (GLM) with adjustments for
age, sex, BMI, smoking, drinking, systolic BP, diastolic
BP, and baseline values were used to compare the three
groups. Spearman’s correlation coefficients were used to
determine relationships between variables. After deter-
mining whether data was normally distributed by the
Kolmogorov-Smirnov and Shapiro-Wilk W tests, a loga-
rithmic transformation was applied to non-normal data
before statistical analysis. For descriptive purposes, the
results are expressed as untransformed and unadjusted
mean values. Continuous variables are expressed as
mean ± SEM, and categorical variables are expressed as
absolute numbers and percentages. A two-tailed value of
P less than 0.05 was considered significant.
Results
Baseline clinical characteristics and dietary intake
Table 1 shows the baseline clinical characteristics of the
study subjects. Anthropometric and biochemical para-
meters before treatment were not significantly different
Table 1 Anthropometric parameters and blood pressure before and after intervention
Placebo (n = 19) Low-dose (n = 19) High-dose (n = 19) Pa)
Age (yr) 37.0 ± 2.24 36.4 ± 1.73 35.3 ± 1.68 0.910
Male / Female (n) 7/12 7/12 9/10 0.747
Body mass index (BMI; kg/m2)
Pre-treatment 23.4 ± 0.60 24.0±0.93 23.5±0.70
Post-treatment 23.6 ± 0.67 24.3±0.93 23.6±0.65
Change 0.27±0.16 0.26±0.15 0.11±0.14 0.850
Cigarette smoker, n (%) 8 (42.1) 6 (31.6) 8 (42.1) 0.948
Alcohol drinker, n (%) 15 (78.9) 13 (68.4) 13 (68.4) 0.706
Blood pressure (mmHg)
Systolic blood pressure (mmHg)
Pre-treatment 115.3±2.92 118.8±3.22 117.5±2.32
Post-treatment 114.7±2.08 118.8±3.10 118.2±1.94
Change −0.55±1.97 −0.03±0.19 0.74±1.65 0.740
Diastolic blood pressure (mmHg)
Pre-treatment 76.6±1.83 80.6±1.98 78.4±1.81
Post-treatment 75.6±1.93 77.3±2.14* 76.2±1.71
Change −0.92±1.88 −3.29±1.28 −2.16±1.75 0.599
Results are expressed as mean± standard error of the mean (SEM) or n (%).
Baseline values for the placebo and test groups were not significantly different (nonparametric Kruskal-Wallis test).
*P< 0.05 compared with the baseline in each group (Wilcoxon signed-rank test).
a) Evaluated by nonparametric Kruskal-Wallis test.
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had no significant effect on BMI and blood pressure.
After treatment, serum lipid profiles (e.g., total choles-
terol, triglyceride, HDL- and LDL-cholesterol) and safety
parameters (e.g., liver and kidney function tests,
complete blood count) did not differ among groups
(data not shown). In addition, no significant differences
were observed for daily nutrient intake before and after
the intervention in all the groups (Table 2).
Antioxidant enzyme activities
Plasma SOD activity after the 8-week KRG supplementa-
tion was significantly higher than baseline activity (low-
dose; P= 0.038, high-dose; P= 0.016), and the net changes
were significantly different between the high-dose group
and the placebo group (P= 0.021) after adjusting for age,
sex, BMI, smoking, drinking, systolic BP, diastolic BP, and
baseline values (Table 3). The plasma GPx and catalase
activities after the 8-week high-dose supplementation
were higher than baseline (P= 0.006 and 0.016, respect-
ively), and the net changes also were significantly different
between the high-dose group and the placebo group
(P= 0.032 and 0.019, respectively) after adjustment.
Erythrocyte SOD and catalase activities were also mea-
sured. No significant differences were observed in the
baseline activities of both enzymes among the three
groups (SOD: placebo, 44.1 ± 3.14; low-dose, 46.0 ± 2.93;
high-dose; 42.3 ± 2.99; Catalase: placebo, 231.1 ± 1.91;low-dose, 224.3 ± 3.48; high-dose; 223.7 ± 2.78). After the
eight weeks, the activities of both enzymes were signifi-
cantly increased in the high-dose group (p< 0.05). In par-
ticular, the net changed values for erythrocyte SOD
activities were significantly different among the three
groups after the adjustment (SOD: placebo, -3.58 ± 2.39;
low-dose, -0.07 ± 1.81; high-dose; 3.50± 1.95, p = 0.030;
Catalase: placebo, -6.74 ± 2.94; low-dose, 1.21 ± 3.45; high-
dose; 4.46 ± 2.55, p = 0.120).
Lymphocyte DNA damage
The DNA tail length significantly decreased after KRG
supplementation compared to baseline (low-dose;
P= 0.004, high-dose; P= 0.003; Figure 1). The tail mo-
ment was also significantly reduced by KRG supplemen-
tation (low-dose; P= 0.012, high-dose; P= 0.001). The
net changes in tail length and tail moment differed sig-
nificantly between the high-dose group and the placebo
group (P= 0.032 and P= 0.019, respectively) after adjust-
ment. The images showing lymphocyte DNA damage, as
performed by comet assay before and after the treat-
ment, between the placebo and high-dose groups are
presented in Figure 1.
Oxidative stress biomarkers, oxidized LDL, and urinary 8-
epi-PGF2α
After 8 weeks, the plasma oxidized LDL levels decreased
in the low-dose (P= 0.003) and high-dose (P= 0.001)
Table 2 Daily energy expenditure and nutrient intake before and after intervention
Placebo (n = 19) Low-dose (n= 19) High-dose (n= 19) Pa)
Total energy expenditure (kcal)
Pre-treatment 2329.3±78.9 2331.8±90.5 2299.5±57.6
Post-treatment 2268.3±76.7 2273.2±98.1 2300.0±68.1
Change −61.0±36.9 −58.6±33.6 0.50±32.9 0.317
Estimates of dietary nutrient intake
Total calorie intake (kcal)
Pre-treatment 1789.2±79.6 1726.4±104.4 1847.9±114.2
Post-treatment 1892.9±72.9 1820.1±81.9 1966.3±97.8
Change 103.7±79.0 93.7±69.1 118.4±75.1 0.991
Carbohydrate (%)
Pre-treatment 60.0±1.57 60.8±1.09 62.4±0.92
Post-treatment 61.2±1.66 59.9±1.72 61.1±1.34
Change 1.16±1.78 −0.94±1.78 −1.28±1.44 0.767
Protein (%)
Pre-treatment 16.0±0.61 16.3±0.62 15.8±0.42
Post-treatment 16.5±0.75 16.0±0.61 15.4±0.53
Change 0.56±0.86 −0.36±0.75 −0.38±0.67 0.280
Fat (%)
Pre-treatment 24.4±1.47 23.9±1.05 22.4±1.07
Post-treatment 22.7±1.79 24.3±1.55 22.9±1.14
Change −1.67±1.65 0.43±1.22 0.50±1.22 0.733
TEE/TCI
Pre-treatment 1.37±0.11 1.43±0.09 1.34±0.09
Post-treatment 1.23±0.06 1.29±0.08 1.23±0.07
Change −0.14±0.10 −0.14±0.07 −0.12±0.07 0.990
Results are expressed as standard error of the mean (SEM).
No significant differences in the week 0 value between the placebo and test groups were found by nonparametric Kruskal-Wallis test.
a) Evaluated by nonparametric Kruskal-Wallis test.
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The net changes differed significantly between the KRG
supplementation groups and the placebo group (vs. low-
dose, P= 0.001; vs. high-dose, P <0.001) after adjustment
(Figure 1). We also found significant differences in the
net changes of urinary excretion of 8-epi-PGF2α between
the KRG supplementation groups and the placebo group
(vs. low-dose, P= 0.033; vs. high-dose, P= 0.049) after
adjustment (Table 3).
Relationship between changes in oxidative stress markers
and catalase activity
Among all subjects, changes in oxidized LDL from base-
line correlated positively with changes in urinary 8-epi-
PGF2α (r= 0.305, P= 0.030), negatively with changes in
catalase activity (r=−0.419, P= 0.002), and appeared to
correlate positively with changes in DNA tail moment
(r= 0.231, P= 0.096); however, this correlation was not
significant. After adjusting for sex and age, changes inoxidized LDL correlated positively with both changes in
urinary 8-epi-PGF2α (r= 0.332, P= 0.026) and DNA tail
moment (r= 0.295, P= 0.049) and correlated negatively
with changes in catalase activity (r=−0.401, P= 0.006).
Discussion
It has been reported that about 200 substances, such as
ginsenosides, polysaccharides, polyacetylenes, peptides,
and amino acids etc, have been isolated from Korean gin-
seng, and more than 100 substances have also been iso-
lated from American ginseng and Notoginseng [19,20].
Among the substances isolated from ginseng, ginseno-
sides are the primary active components of ginseng [21].
According the recent report, more than 60 ginsenosides
have been found in the American ginseng [22]. These gin-
senosides have been discovered continuously in the Ko-
rean ginseng, and it has been assumed that Korean
ginseng contains over 60 ginsenosides [20]. Furthermore,
Korean ginseng contains more primary non-saponin
Table 3 Antioxidant enzyme activity and lipid peroxidation before and after intervention
Placebo (n= 19) Low-dose (n = 19) High-dose (n= 19)
SOD activity (U/ml)
Pre-treatment 12.6±0.97 10.1±0.68 11.9±0.98
Post-treatment 12.2±0.96 12.1±1.03* 14.2±1.15*
Change −0.46±0.57 1.95±0.80 2.24±0.86†
GPx activity (nmol/min/ml)
Pre-treatment 41.1±3.71 34.3±1.88 34.9±2.53
Post-treatment 39.1±3.72 37.4±2.27 43.5±2.53**
Change −2.00±2.08 3.05±2.15 8.66±2.63†
Catalase (nmol/min/ml)
Pre-treatment 103.2±11.5 94.5±8.56 86.9±11.7
Post-treatment 99.0±13.2 118.3±11.8 135.5±12.3**
Change −4.17±12.4 23.8±12.4 48.5±12.3†
8-epi-PGF2α (pg/mg creatinine)
a)
Pre-treatment 1450.3±103.7 1519.0±222.3 1516.3±105.9
Post-treatment 1641.6±136.5 1323.4±106.6 1383.5±120.2
Change 191.3±107.7 −195.6±147.6† −132.8±127.9†
SOD, superoxide dismutase; GPx, glutathione peroxidase; 8-epi-PGF2α, 8-epi-prostaglandin F2α.
a)Tested after logarithmic transformation.
Results are expressed as standard error of the mean (SEM).
Tested by Wilcoxon signed-rank test or analysis of covariance (ANCOVA) using a general linear model (GLM) with adjustments for age, sex, BMI, smoking, drinking,
systolic BP, diastolic BP, and baseline values.
*P <0.05,**P <0.01 compared with the baseline in each group; †P <0.05, ††P <0.01 compared with the placebo group.
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and polyethylene compounds than American ginseng or
Sanchi ginseng [23]. KRG is produced by a special process
of steaming and drying fresh Korean ginseng. The steam-
ing process hydrolyzes and converts ginsenosides into
other types of ginsenosides, such as red ginseng-specific
compounds with anticancer properties (ginsenoside-Rh2,
-Rh4, -Rs3, -Rs4, -Rg5) and a compound with anti-
metastasis and vasodilation properties (ginsenoside-Rg3).
The anti-oxidative and anti-cancer activities of KRG ap-
pear to be superior to those of white ginseng [21,24].
The reduction in oxidative DNA damage after KRG
supplementation observed in the present study is consist-
ent with findings from a previous study using a rat model.
Park et al. [25] reported that red ginseng extract inhibited
the breaking of Escherichia coli ColE1 plasmid DNA as
well as the nuclear DNA of rat hepatocytes damaged by
oxidative stress. In the present study, 8 weeks of KRG
supplementation (6 g/day) significantly decreased DNA
tail length (μm) and tail moment, indicators of lympho-
cyte DNA damage, compared to placebo. Zhang et al.
[26] also reported in mice that a 2-day oral administration
of 20(S)-ginsenoside Rg3 (20 mg/kg per day) significantly
inhibited cyclophosphamide-induced DNA damage in
bone marrow cells and peripheral lymphocytes.
Oxidative stress results from an imbalance between
antioxidants and reactive oxygen species, such as super-
oxide anions, H2O2, and hydroxyl radicals [27]. Highlevels of reactive oxygen species damage biomolecules
(nucleic acids, proteins, and lipids) and generate oxi-
dized LDL, which upregulates lectin-like oxidized low-
density lipoprotein receptor-1 in endothelial cells,
thereby inducing the generation of more reactive oxygen
species through an unclear intracellular feedback mech-
anism [28]. The antioxidant enzyme SOD eliminates
superoxide anions by producing H2O2 and is the first
line of defense against reactive oxygen species toxicity.
Furthermore, the enzymes catalase and GPx convert
harmful H2O2 to harmless H2O [3,29]. Thus, boosting
the activity of these three main antioxidant enzymes by
KRG supplementation may decrease oxidative stress.
In the present study, plasma SOD, catalase, GPx, and
erythrocyte SOD activities were significantly higher in
subjects who received KRG supplementation than in
subjects who received the placebo. In the past, the anti-
oxidative effects of KRG have primarily been demon-
strated in animal models or in vitro studies. Kim et al.
[30] reported that, in mice subjected to paraquat-
mediated oxidative stress, SOD, catalase, and GPx levels
in liver tissue were significantly increased by red ginseng
saponin supplementation. In a separate publication, Kim
et al. [31] demonstrated that ginsenoside Rh2, a charac-
teristic ginsenoside of red ginseng, is a particularly im-
portant active compound that significantly boosts
catalase activity. Similarly, Chang et al. [32] reported
that the Rb2 subfraction of panaxadiol ginsenosides
BA
Figure 1 Effects of 8-week supplementation of Korean red ginseng (KRG) on lymphocyte DNA damage LDL oxidation. A. Comparison of
mean values for damaged tail length (μm) and tail moment in lymphocyte DNA and the concentrations of oxidized LDL (U/L). B. Images of
lymphocyte DNA damage performed by comet assay before and after treatment between the placebo and high-dose groups. ∮Tested after log
transformation. P values represent significant differences by analysis of covariance (ANCOVA) using a general linear model (GLM) with
adjustments for age, sex, BMI, smoking, drinking, systolic BP, diastolic BP, and baseline values. *P <0.05,**P <0.01, and ***P <0.001 compared with
the baseline in each group; †P <0.05, ††P <0.01 , †††P <0.001 compared with the placebo group.
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maintain cell viability by lowering the level of oxygen
radicals generated by the intracellular metabolism.
The limitations of our study include a small sample
size, which renders us unable to generalize our study
findings to other populations. We were also limited by
the short study duration, and the mechanisms of action
were not addressed in the study design. The important
findings presented in this study will require further in-
vestigation in larger trials that will be carefully designed
to include the optimal dose and form of KRG interven-
tion, the study duration, and subject characteristics. In
addition, enzyme mass and gene and protein expression
levels should be measured to determine whether the
increased enzyme activity is due to an increase in pro-
tein mass or through the elevation of the specific activ-
ities of the enzyme.Conclusions
In this randomized, double-blind, placebo-controlled
study, KRG supplementation improved biomarkers of
oxidative stress, as evidenced by decreased plasma oxi-
dized LDL, attenuated lymphocyte DNA damage and
increased plasma antioxidant enzyme activity in healthy
participants (20–65 years old). In addition, changes in
plasma oxidized LDL correlated positively with the
decreases in oxidative DNA damage and urinary 8-epi-
PGF2α and negatively with changes in catalase activity.
Larger prospective studies with a longer intervention
period (3 or 6 months) will be necessary to further
characterize the beneficial antioxidative activity of KRG
and its mechanism of action.
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